Overview

Rapid Start vs. Standard Start Antiretroviral Therapy (ART) in HIV

Status:
Recruiting
Trial end date:
2022-12-01
Target enrollment:
Participant gender:
Summary
This study plans to learn about whether starting HIV treatment very soon after diagnosis is more beneficial than waiting until entering routine clinical care after diagnosis.
Phase:
Phase 4
Details
Lead Sponsor:
University of Colorado, Denver
Collaborator:
Gilead Sciences
Treatments:
Anti-Retroviral Agents
Emtricitabine
Emtricitabine tenofovir alafenamide
Tenofovir